QRxPharma names new executive vice president

Prior to joining QRxPharma, Mr Soriano was senior director of business development at Osiris Therapeutics and responsible for all business development activities, including IP strategy and operations, out-licensing and divestiture.

John Holaday, managing director and CEO of QRxPharma, said: “We are very pleased to announce that Dr Soriano has joined our senior management team. Our approach has been to build a team of people who add value, broaden our collective knowledge and bring the experience necessary to advance the company’s goals. I am confident Dr Soriano will contribute significantly to QRxPharma’s success.”